ABOUT · HERITAGE
Our founders pioneered automated particle-resolved Raman analysis in the late 1990s and early 2000s, developing patented workflows that combined particle detection, sizing and automated spectroscopic identification.
Do not only count particles. Identify what they are.
From APSys to rap.ID and today’s SizeID.bio, the analytical goal has remained consistent: connect particle populations to material identity and useful interpretation.
The story began at Schering, where Markus Lankers encountered a practical challenge during the aseptic manufacture of a powdered pharmaceutical product.
The team needed to understand the origin of particles detected in the cleanroom air.
Product particles or contamination?
Conventional particle counting could not distinguish between product-related material, foreign particles and microorganisms. Answering that question required chemical identification at the level of individual particles.
This challenge inspired the development of an automated, image-first approach: first locate particles using microscopy, then identify their chemical composition through targeted Raman spectroscopy.
What began as cleanroom air monitoring soon expanded into pharmaceutical product analysis. Through APSys and rap.ID, the technology found applications in parenteral products, inhalation formulations, pharmaceutical raw materials and foreign-particle investigations.
Microbiology was part of the development almost from the beginning. Since 2004, Raman-based microorganism identification had been pursued in parallel, including applications in cleanroom monitoring.
With the founding of mibiC in 2019, microbial analysis became the main focus. This work advanced our expertise in automated image interpretation, machine learning and deep learning.
Back to the roots. With new intelligence.
With SizeID.bio, the story comes full circle.
We return to automated pharmaceutical particle analysis — now applying the experience and computational methods developed through years of microbial Raman research to the original challenge.
Today, the GramRay i MK3 combines automated microscopy, DeepMorph image analysis and targeted Raman spectroscopy for advanced particle characterization and chemical identification.
Explore our scientific publications →
Our journey
Late 1990s
Schering — The original challenge
Distinguishing product-related particles from contamination during aseptic pharmaceutical manufacturing inspired the idea of automated chemical particle identification.
1999–2001
APSys — Automated particle Raman analysis
Early systems combined automated microscopy with targeted Raman spectroscopy for chemical identification of individual particles in cleanroom monitoring.
2000s
rap.ID — From air to pharmaceutical products
Pharmaceutical demand expanded particle identification into parenterals, inhalation products, raw materials and contamination investigations.
Since 2004
Microbial Raman — A parallel development path
Raman-based microorganism identification developed alongside pharmaceutical particle analysis, including cleanroom applications.
2019 onward
mibiC — Intelligence through microbiology
With mibiC, microbial analysis became the primary development focus, bringing advances in automated image interpretation, machine learning and deep learning.
Today
SizeID.bio — Back to the roots
The GramRay i MK3 brings automated particle Raman analysis together with DeepMorph, applying new image-analysis capabilities to pharmaceutical particle characterization.
Built through pharmaceutical use at scale
Through rap.ID, the technology was applied across more than 100 pharmaceutical customers, thousands of analytical projects and tens of thousands of particle-analysis runs.
Historical rap.ID experience refers to the predecessor companies and laboratories. SizeID.bio is the current particle-analysis offering of mibiC GmbH & Co. KG.
Discuss your analysis